Cyclooxygenase-2 expression and oxidative DNA adducts in murine intestinal adenomas: Modification by dietary curcumin and implications for clinical trials

This publication has 22 references indexed in Scilit:

• Curcumin: The story so far
  European Journal Of Cancer, 2005
• Phase I Clinical Trial of Oral Curcumin
  Clinical Cancer Research, 2004
• An improved liquid chromatography/tandem mass spectrometry method for the determination of 8‐oxo‐7,8‐dihydro‐2′‐deoxyguanosine in DNA samples using immunoaffinity column purification
  Rapid Communications in Mass Spectrometry, 2002
• The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
  New England Journal of Medicine, 2000
• Oxyradicals and DNA damage
  Carcinogenesis: Integrative Cancer Research, 2000
• Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signalling complex
  Oncogene, 1999
• H-Atom Transfer Is A Preferred Antioxidant Mechanism of Curcumin
  Journal of the American Chemical Society, 1999
• Strategy and planning for chemopreventive drug development: Clinical development plans II
  Journal of Cellular Biochemistry, 1996
• Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane)
  Journal of Biological Chemistry, 1995
• Genetic Alterations during Colorectal-Tumor Development
  New England Journal of Medicine, 1988